Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1

Conditions

Gynecologic Cancer 1

Interventions

Paclitaxel 150 Carboplatin 110 Cisplatin 94 Bevacizumab 42 Topotecan 39 Gemcitabine 38 liposomal doxorubicin 34 Radiotherapy 29 Doxorubicin 27 Brachytherapy 26 Taxes 24 pembrolizumab 20 olaparib 20 Drug Therapy 20 Hyperthermic Intraperitoneal Chemotherapy 16 Chemotherapy, Adjuvant 16 human papillomavirus vaccine, L1 type 16, 18 15 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14 Docetaxel 13 Neoadjuvant Therapy 12 Platinum 10 niraparib 9 Radiation 9 1,2-diaminocyclohexaneplatinum II citrate 9 Vaccines, Synthetic 8 Surgical Procedures, Operative 8 atezolizumab 7 Specimen Handling 7 Papillomavirus Vaccines 7 Letrozole 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Preoperative Exercise × Gynecologic × Clear all

NCT04596800 2023-10-31

PROPER

Instituto Brasileiro de Controle do Cancer

Phase 3 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡